Logo-ps

 

 

 

Follower of ICMJE

Powered by:
Pharm Sci. 2020;26(3): 338-342. doi: 10.34172/PS.2020.42

Short Communication

Dabigatran versus Warfarin for the Treatment of Pediatric Thromboembolism: A Pilot Randomized Trial

Aziz Eghbali 1 ORCID, Roghayyeh Rahimi Afzal 2, Roya Sheikhbeygloo 2, Aygin Eghbali 1, Bahar Taherkhanchi 3, Bahador Bagheri 4,5 * ORCID

Cited by CrossRef: 5

1- Guan C, Guo L, Liang S. Systematic Review of Randomized Clinical Trials on Direct Oral Anticoagulants in Pediatric Heart Diseases. Clin Appl Thromb Hemost. 2024;30 [Crossref]
2- Giossi R, Menichelli D, D’Amico F, Idotta L, Cirino M, Scardoni L, Furlanetto C, Maggi M, Bernocchi O, Bosca F, Girlando L, Pignatelli P, Pani A, Pastori D, Tozzo A, Scaglione F, Fornasari D. Efficacy and safety of direct oral anticoagulants in the pediatric population: a systematic review and a meta-analysis. Journal of Thrombosis and Haemostasis. 2023;21(10):2784 [Crossref]
3- Yu X, Zhu W, Liu C, Lu R. Direct Oral Anticoagulants for Treating Acute Venous Thromboembolism in Children: Meta-Analysis of Randomized Controlled Trials. Clin Appl Thromb Hemost. 2024;30 [Crossref]
4- O’Brien S, Duignan S, Crumlish K, O’Donoghue J, Franklin O, McMahon C. Anticoagulation with warfarin for paediatric cardiac indications: a retrospective study. Cardiol Young. 2025;35(2):407 [Crossref]
5- Gao H, Chen M, Huang Y, Liu H, Lin Y, Chen M. Efficacy and safety of antithrombotic therapy for preventing and treating pediatric thromboembolic disease: a systematic review. Sci Rep. 2024;14(1) [Crossref]

   Indexing & Abstracting: